Machine Learning in Oncology: Transforming Cancer Detection and Treatment

Abstract

Cancer continues to represent one of the greatest global health challenges, accounting for millions of new diagnoses and deaths annually. The biological complexity of malignant diseases, characterized by extensive genomic heterogeneity, dynamic tumor evolution, immune interactions, and variable therapeutic responses, presents substantial challenges for clinicians seeking to deliver individualized patient care. Conventional oncology relies heavily on histopathology, radiological imaging, molecular diagnostics, and clinical expertise; however, these approaches often face limitations related to diagnostic variability, delayed interpretation, and the inability to simultaneously analyze large-scale multidimensional datasets. Machine learning (ML), a major branch of artificial intelligence, has emerged as a transformative technology capable of overcoming many of these limitations by identifying complex patterns within biomedical data that are beyond human analytical capacity. Supervised, unsupervised, semi-supervised, and reinforcement learning algorithms have demonstrated remarkable capabilities across the entire cancer care continuum, including early detection, tumor classification, biomarker discovery, prognostic prediction, treatment selection, response assessment, and survival estimation. Recent advances in deep learning, ensemble learning, transfer learning, explainable artificial intelligence, and multimodal data integration have further expanded the clinical applicability of ML in oncology. Machine learning systems now integrate histopathological images, radiological scans, genomic and transcriptomic profiles, proteomic signatures, electronic health records, and real-world clinical data to support precision oncology and personalized treatment planning. Despite these advances, challenges including algorithmic bias, data privacy, interpretability, regulatory validation, and clinical implementation remain significant barriers to widespread adoption. This review discusses the evolution, methodologies, clinical applications, advantages, limitations, ethical considerations, and future perspectives of machine learning in transforming modern cancer detection and treatment.